SMS Lifesciences India Limited — Board Meeting, 12-02-2025: Outcome of Board Meeting

The Board of SMS Lifesciences India Limited has approved the un-audited financial results for the quarter and nine months ended December 31, 2024. Key highlights include a revenue from operations of ₹82.88 crore for the quarter, resulting in a net profit of ₹62.28 crore. Additionally, Mrs. Sundaramma Patibandla has been appointed as an Additional Director, and Mr. Veeravenkata Satyanarayana Murthy Talluri has been reappointed as Managing Director for three more years starting June 1, 2025, both subject to shareholder approval.